Repatha and Lescol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repatha (evolocumab) and Lescol (fluvastatin sodium). Common drug interactions include drug ineffective among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Repatha and Lescol. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,256 Repatha users. Check the latest studies of Repatha.

What is Lescol?

Lescol has active ingredients of fluvastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 7,306 Lescol users. Check the latest studies of Lescol.



On Jul, 07, 2026

63 people who take Repatha and Lescol together, and have interactions are studied.

Repatha and Lescol drug interactions.

What are the common drug interactions of Repatha and Lescol, by gender? *:

female:

  1. Drug ineffective
  2. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Insomnia (sleeplessness)
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  8. Asthenia (weakness)
  9. Cardiovascular disorder (heart diseases)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Drug ineffective
  3. Food allergy
  4. Headache (pain in head)
  5. Multimorbidity (co-occurrence of two or more chronic medical conditions in one person)
  6. Respiratory distress (difficulty in breathing)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Cardiac disorder

What are the common drug interactions of Repatha and Lescol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Drug ineffective
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

20-29:

  1. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  2. Cardiac disorder
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Drug ineffective
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Multimorbidity (co-occurrence of two or more chronic medical conditions in one person)

30-39:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Drug ineffective
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Cardiac disorder
  6. Low density lipoprotein increased (cholesterol increased in blood)
  7. Multimorbidity (co-occurrence of two or more chronic medical conditions in one person)

40-49:

  1. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Adverse drug reaction
  4. Drug ineffective
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

  1. Arthralgia (joint pain)
  2. Headache (pain in head)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  5. Cardiovascular disorder (heart diseases)
  6. Drug ineffective
  7. Acute myocardial infarction (acute heart attack)
  8. Attention deficit/hyperactivity disorder
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

60+:

  1. Asthenia (weakness)
  2. Nausea (feeling of having an urge to vomit)
  3. Pain in extremity
  4. Oral discomfort (pain or irritation in mouth)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Back pain
  7. Blood glucose increased
  8. Hypotension (abnormally low blood pressure)
  9. Influenza like illness
  10. Insomnia (sleeplessness)

What are the existing conditions these people have? *

  1. Low Density Lipoprotein: 36 people, 57.14%
  2. Low Density Lipoprotein Abnormal (cholesterol abnormal): 14 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and Lescol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Repatha and Lescol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lescol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repatha and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lescol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on evolocumab and fluvastatin sodium (the active ingredients of Repatha and Lescol, respectively), and Repatha and Lescol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: